Image Source: Pixabay

Tsumura & Co (TSMRF) is a specialty and generic drug manufacturing company.

It generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines.

Tsumura promotes its products through educational efforts at medical schools and by hosting seminars for physicians and consumers.

The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing skills.

Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.

Three key data points gauge Tsumura or any dividend-paying firm.

The key three are:

(1) Price

(2) Dividends

(3) Returns

Those three keys also best tell whether any company has made, is making, and will make money.

TSMRF Price

Tsumura’s price grew about 9% in the past year from $25.86 to $28.15 as of Thursday’s market close.

In the past 3 years, the company’s share price has ranged from $18.10 to $28.15. However, the all-time high price of $34.68 was reached on June 11th, 2021.

Should Tsumura conform to the average $2.38 of one year price gains charted over the past three years, its share price could grow to over $30.50 in the coming year.

TSMRF Dividends

Tsumura has paid variable semi-annual dividends since June 2014. The company’s most recent SA dividend of $0.4534 was declared last May 9th for shareholders of record prior to this March 28th, and the payout is due near the end of June. So there’s a day to book this payout. The forward-looking annual dividend of $0.91 yields 3.22% per Thursday’s closing price.

TSMRF Returns

Putting it all together, a $3.76 estimated gross gain per share shows up by adding Tsumura’s annual $0.91 dividend to the estimated $2.85 estimated annual gross price gain, totaling that $3.76 gross gain amount.

A little under $1000 buys 35.5 shares at Wednesday’s $28.15 share price.

So, a $10 broker fee (if charged), collected half at purchase and half at sale, might take about $0.28 per share out of the $3.76 gross gain to give us a $3.48 net amount per share to multiply by 35.5 shares.

That result comes to $123.54 for about a 12% estimated net gain in the coming year.

Furthermore, $32.20 in annual dividend income from your $1,000 investment in Tsumura & Co is about 14.4% greater than the $28.15 single-share price.

By these numbers, Tsumura could be considered an ideal dividend dog by my dogcatcher standards.

Therefore, you may choose to pounce on Tsumura & Co Ltd as a 132-year-old semi-annual dividend-paying Japanese Kampo traditional health care company with an 11-year semi-annual dividend payment record.

The exact track of Tsumura’s future price and dividend will entirely be determined by market action and company finances.   

Remember, the best way to track stock performance and dividend payments is through direct ownership of company shares.

More By This Author:

Current Report: Sundrug
Current Report: Koninklijke Philips
Current Report: Sienna Senior Living